Leadership & Clinical Governance

Perry Myers is a visionary entrepreneur dedicated to advancing regenerative medicine and expanding access to cutting-edge stem cell therapies. As Founder and CEO of Infinite Medical, he has carefully assembled a team of top doctors, nurses, and medical experts, ensuring every patient receives world-class regenerative treatments.

Pioneering Innovation in Modern Healthcare - 
With a background in medical technology, global healthcare, and corporate leadership, Perry has led multiple successful ventures, including Belle Medical, where he pioneered minimally invasive medical treatments. His ability to identify and implement breakthrough medical innovations has made him a leader in transforming healthcare. Driven by a passion for science-backed, patient-centered care, Perry ensures that Infinite Medical's treatments are safe, effective, and designed to optimize long-term health and healing. His leadership continues to push the boundaries of what's possible in regenerative medicine.

Dr. Thom E. Lobe leads clinical strategy, operative standards, and medical governance across Infinite Medical Group. An internationally recognized surgeon, researcher, and pioneer in minimally invasive techniques, Dr. Lobe brings an extraordinary academic pedigree shaped at institutions including Harvard, Johns Hopkins, the University of Pennsylvania, and the University of Maryland, where he graduated Cum Laude. Over an illustrious career that includes serving as Chief of Pediatric Surgery at St. Jude Children’s Research Hospital and Professor of Clinical Surgery, he has authored more than 250 peer-reviewed publications and received lifetime achievement honors across three continents.

As a Master Fellow of the International Board of Regenerative Medicine (FIBRM), Dr. Lobe anchors our mission to replace outdated symptom-masking with authentic biological restoration. Having spent decades advancing regenerative wound healing, metabolic science, and cellular therapies, he directs the non-cytotoxic mandates and image-guided protocols that govern every procedure we perform.

With over 17 years of dedicated experience in acute care and executive leadership, Janine Gasper serves as the Chief Nursing Officer, where she bridges the gap between clinical excellence and strategic growth. Her extensive background includes critical roles in emergency and cardiac care at prestigious institutions such as Loma Linda University Health and Trinity Health of New England.

At the heart of Janine's leadership is a commitment to the "Infinite" brand integrity, ensuring that every patient touchpoint reflects the highest regulatory standards and compassionate care. She oversees the complex intersection of clinic operations, nursing personnel, and the specialized Synergy and Concierge programs. A specialist in program creation and staff development, Janine is passionate about building sustainable clinical frameworks and mentoring the next generation of nursing leaders to achieve their full potential.

Cheyanne has spent years spearheading our Synergy Partnership Program, acting as the bridge between cutting-edge science and the providers who bring it to life. From hosting transformative conferences to guiding providers through our exclusive lab portal, she has been the architect of a network that spans the entire United States. Her dedication ensures that patients everywhere have access to the absolute gold standard in adipose-derived MSCs. Cheyanne doesn't just onboard partners; she builds a community dedicated to the BEST in regenerative medicine.

Having been a cornerstone of our organization since the doors first opened, her loyalty is matched only by her warmth. She approaches every partnership with a genuine kindness that turns professional colleagues into a unified community, ensuring that everyone she touches feels seen, supported, and inspired.

As Director of Clinical Research and Grant Development, Kaia Jackman bridges the gap between frontline clinical practice and translational science. A board-certified Family Nurse Practitioner (FNP-C), Kaia is responsible for architecting, funding, and stewarding institutional research protocols that validate the power of autologous cellular medicine. She leads strategic grant development and works closely with institutional review boards to secure vital funding for dedicated clinical trials, ensuring every study meets the highest scientific and ethical benchmarks.


At the heart of Kaia's work is a fierce advocacy for trauma survivors and a deep commitment to restoring what conventional medicine often overlooks. Moving beyond temporary symptom-masking, she champions groundbreaking protocols that utilize autologous cellular therapies to resolve chronic neuro-inflammation and repair deep soft-tissue trauma. For Kaia, regenerative medicine represents far more than an emerging field: it is a transformative path toward restoring physical wholeness and true biological sovereignty.